ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

February 27, 1976

In Congress: DOD Cancer Research Programs Increased; Senate Passes NIH Funding Bill; Porter Won’t Seek Re-election

October 22, 1999

Cancer Meetings Listed For Next Three Months

September 20, 1996

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974